AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
44.41
+1.11 (2.56%)
At close: Dec 5, 2025, 4:00 PM EST
44.35
-0.06 (-0.14%)
After-hours: Dec 5, 2025, 5:01 PM EST
AnaptysBio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,228 | 403 | 569 | 881 | 961 | 588 | |
| Market Cap Growth | 102.07% | -29.23% | -35.39% | -8.28% | 63.38% | 33.35% | |
| Enterprise Value | 1,325 | 340 | 486 | 760 | 608 | 251 | |
| Last Close Price | 44.35 | 13.24 | 21.42 | 30.99 | 34.75 | 21.50 | |
| Forward PE | - | - | - | - | 16.86 | - | |
| PS Ratio | 7.70 | 4.41 | 33.18 | 85.65 | 15.21 | 7.84 | |
| PB Ratio | - | 5.69 | 6.46 | 3.36 | 2.70 | 1.48 | |
| P/TBV Ratio | - | 5.69 | 6.46 | 3.36 | 2.70 | 1.48 | |
| EV/Sales Ratio | 7.82 | 3.72 | 28.31 | 73.84 | 9.62 | 3.34 | |
| Debt / Equity Ratio | -11.78 | 5.21 | 3.73 | 1.24 | 0.76 | 0.00 | |
| Asset Turnover | 0.40 | 0.20 | 0.03 | 0.02 | 0.12 | 0.18 | |
| Quick Ratio | 8.52 | 9.38 | 10.62 | 16.99 | 34.10 | 19.86 | |
| Current Ratio | 8.68 | 9.51 | 10.87 | 17.17 | 34.40 | 20.01 | |
| Return on Equity (ROE) | -308.02% | -182.71% | -93.44% | -41.62% | -15.35% | -4.97% | |
| Return on Assets (ROA) | -4.23% | -15.35% | -18.47% | -11.48% | -6.70% | -3.50% | |
| Return on Capital (ROIC) | -4.66% | -16.77% | -19.58% | -11.85% | -6.93% | -3.71% | |
| Return on Capital Employed (ROCE) | -9.10% | -26.20% | -37.90% | -19.70% | -9.10% | -6.00% | |
| Earnings Yield | -6.89% | -36.05% | -28.74% | -14.61% | -6.02% | -3.39% | |
| FCF Yield | -11.83% | -33.68% | -21.36% | -8.39% | -4.92% | -2.50% | |
| Buyback Yield / Dilution | -7.36% | -5.42% | 4.41% | -2.68% | -0.47% | -0.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.